Manuela Callari XEN-D0501, a transient receptor potential vanilloid 1 (TRPV1) antagonist, is gaining attention for its potential as an oral tablet to treat type 2 diabetes, obesity, and cardiovascular diseases. Dorte X. Gram, PhD, founder of Pila Pharma, a Swedish pharmaceutical company investigating XEN-D0501, first noticed the connection more than 20 years ago as a researcher at...
Tag: <span>anti obesity medications</span>
Post
New Clinical Study Confirms the Anti-Obesity Effects of Kimchi
Regular Consumption Reduces Body Fat and Boosts Gut HealthPeer-Reviewed Publication National Research Council of Science & Technology image: Diagrammatic representation of the results of the clinical trial on the anti-obesity effects of kimchiview more Credit: World Institute of Kimchi (WiKim) Approximately 16% of the global population, or about 890 million people, suffer from obesity. The World...
Post
Knowledge Gaps About Obesity Medicine Seen in Primary Care
San Antonio — Despite the prevalence of obesity in primary care, there appear to be major knowledge gaps among providers regarding obesity management, new research suggests. Anonymous surveys of 96 primary care providers at a Boston, Massachusetts, safety net hospital revealed that participants had limited understanding of criteria for prescribing antiobesity medications (AOM), and expressed...
Post
Knowledge Gaps About Obesity Medicine Seen in Primary Care
San Antonio — Despite the prevalence of obesity in primary care, there appear to be major knowledge gaps among providers regarding obesity management, new research suggests. Anonymous surveys of 96 primary care providers at a Boston, Massachusetts, safety net hospital revealed that participants had limited understanding of criteria for prescribing antiobesity medications (AOM), and expressed...
Post
Anti-obesity drug has life-changing benefits for arthritis
Osteoarthritis, which causes stiff and painful joints, affects the knees most often.Credit: Dr. P. Marazzi/Science Photo Library A blockbuster weight-loss drug sharply reduces pain from obesity-related knee arthritis and improves a person’s ability to engage in activities such as walking. That’s according to a clinical trial conducted in 11 countries — the first of its kind to...
Post
Study identifies factors associated with long-term use of FDA-approved anti-obesity medications
by Cleveland Clinic Percentage of patients who were persistent with antiobesity medication (AOM) at early stage, medium term, and long term, by AOM agent. [Color figure can be viewed at wileyonlinelibrary.com] A Cleveland Clinic study looked at the long-term use of anti-obesity medications and found that only 19% of the study participants continued to use the...